Brief: EQL Pharma's Methenamine Hippurate Approved In Germany
14/11/2025 12:54
Nov 14 (Reuters) - EQL Pharma AB EQL.ST: METHENAMINE HIPPURATE APPROVED IN GERMANY AS CYSTOHIPP CYSTOHIPP LAUNCH PLANNED FOR MID-2026 Source text: ID:nWkr9WYp8S Further company coverage: EQL.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))